FIELD: medicine.
SUBSTANCE: there are described specific semi-soft C-class immunostimulatory CpG oligonucleotides which are used to stimulate immune response. There is offered an immunostimulating pharmaceutical composition containing said oligonucleotidies. There are presented methods of treating asthma, infectious disease and allergy, and modulating the immune response including administration of said oligonucleotide.
EFFECT: invention can be used in treating allergy, such as allergic rhinitis and asthma, cancer and infectious disease, such as hepatitis type B and hepatitis type C.
68 cl, 62 dwg, 12 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOSTIMULATING PHOSPHOROTHIOATE CpG-OLIGONUCLEOTIDES, CONTAINING PHOSPHODIESTER LINKS, METHOD OF IMMUNOMODULATION, METHOD OF IMMUNE RESPONSE STIMULATION | 2003 |
|
RU2338750C2 |
| CPG-OLIGONUCLEOTIDE ANALOGUES, CONTAINING HYDROPHOBIC T-ANALOGUES WITH AMPLIFIED IMMUNOSTIMULATORY ACTIVITY | 2007 |
|
RU2477315C2 |
| IMMUNOSTIMULATING NUCLEIC ACIDS | 2000 |
|
RU2245149C2 |
| IMMUNOSTIMULATING G,U-CONTAINING OLYGORIBONUCLEOTIDES | 2003 |
|
RU2302865C2 |
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
| PNEUMOCOCCAL VACCINE AND USING IT | 2010 |
|
RU2536248C2 |
| PCSK9 VACCINE | 2010 |
|
RU2538162C2 |
| COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION | 2014 |
|
RU2723943C2 |
| IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
| CH3 IGE PEPTIDE VACCINE | 2009 |
|
RU2495049C2 |
